In this free webinar, learn how Pediatric Investigation Plans (PIPs) and Pediatric Study Plans (PSPs) support pediatric access and regulatory alignment. Attendees will gain insight into the practical ...

Drug developers face unique challenges in pediatric rare disease trials, including small and geographically dispersed patient populations, strict ethical limits on sampling and sparse early clinical ...

Children with acute lymphoblastic leukemia (ALL) are treated according to risk-based protocols defined by the Children's Oncology Group (COG). Alignment between real-world clinical practice and ...

Please provide your email address to receive an email when new articles are posted on . Use of a modified pediatric protocol produced favorable outcomes for adolescents and young adults with acute ...

An electronic sepsis alert using a combination of vital signs, risk factors and physician judgment to identify children in a pediatric emergency department with severe sepsis reduced missed diagnoses ...

Preterm infants, especially extremely low gestational age neonates (ELGANs), are predisposed to pulmonary complications such as bronchopulmonary dysplasia. Assessment of lung function is critical for ...

WASHINGTON -- An electronic sepsis alert using a combination of vital signs, risk factors and physician judgment to identify children in a pediatric emergency department with severe sepsis reduced ...

We report here the outcomes and late effects of the Japanese Study Group for Pediatric Liver Tumors (JPLT)-2 protocol, on the basis of cisplatin-tetrahydropyranyl-adriamycin (CITA) with risk ...

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that an expanded access protocol (EAP) for Oxbryta® (voxelotor) in ...

Introduction Globally, up to 15% of children and adolescents experience a mental health (MH) condition. In the UK, an increasing number of children and young people (CYP) are presenting to acute ...